We believe Perrigo is in fine financial health. At the end of 2024, the company had roughly $560 million in cash and equivalents with about $3.3 billion in long-term debt. Its balance sheet was in a ...

New emerging life sciences hubs are gaining ground amid the market shift.

J&J's stock price is down from its 2022 peak, but it's performed better than you might think by simply looking at its chart.

After years of post-COVID-19 normalization and the impact of its Kenvue spinoff, Johnson & Johnson’s (NYSE: JNJ) stock price ...

What a bunch of babies!” That was my reaction when, as an ardent believer in technical analysis over narratives, meme stocks, and Federal Reserve mania, I read that market expectations for a Fed rate ...

Bitmine Immersion Technologies (BMNR) is up more than 20% in afternoon trading after billionaire investor Peter Thiel ...

Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...

In a testament to its enduring strength and adaptive strategy, Johnson & Johnson (NYSE: JNJ) today announced a strong ...

Shoppers aged 45 to 60 now make up 25% of total spend for the beauty category, favouring products that ‘balance benefits with ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.58, a high estimate of $25.00, ...

Its stock rose 2.9%, though it also said that market conditions remain sluggish. Shares of Kenvue rose 2.3% in shaky trading after the former division of Johnson & Johnson said CEO Thibaut Mongon is ...

Real-time index price for TSX Composite Index (TXCX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...